FDA Requires Updates to ADHD Medication Labeling
Pharma Leaders
MAY 15, 2023
Manufacturers of amphetamine and methylphenidate products, a class of stimulant medications used to treat ADHD and other disorders, must update their labeling and prescribing information to “clearly inform” patients, caregivers and healthcare professionals risks associated with these medications.
Let's personalize your content